Literature DB >> 19602487

Severe infections in HIV-exposed uninfected infants: clinical evidence of immunodeficiency.

A L Slogrove1, M F Cotton, M M Esser.   

Abstract

We describe the clinical and basic immunological findings of eight HIV-exposed uninfected infants hospitalized with serious infectious morbidity and referred for immunological evaluation. The median age at presentation was 5.5 (1.5-15) months. Infections included Pneumocystis jiroveci pneumonia (three), cytomegalovirus colitis with perforation (one), Pseudomonas sepsis (two), hemorrhagic varicella (one) and Group A streptococcal meningitis and endocarditis (one). Five required intensive care, four for assisted ventilation and one for post-surgical care. Follow-up to 36 months suggested resolution of a transient immunodeficiency in two infants, one of whom had CD4 and the other B-cell depletion. Further studies are indicated in HIV-exposed uninfected infants.

Entities:  

Mesh:

Year:  2009        PMID: 19602487     DOI: 10.1093/tropej/fmp057

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  41 in total

1.  Outcomes of a National Institute of Allergy and Infectious Diseases Workshop on understanding HIV-exposed but seronegative individuals.

Authors:  Janet M Young; Jim A Turpin; Runa Musib; Opendra K Sharma
Journal:  AIDS Res Hum Retroviruses       Date:  2011-01-15       Impact factor: 2.205

2.  Immune-based approaches to the prevention of mother-to-child transmission of HIV-1: active and passive immunization.

Authors:  Barb Lohman-Payne; Jennifer Slyker; Sarah L Rowland-Jones
Journal:  Clin Perinatol       Date:  2010-12       Impact factor: 3.430

Review 3.  Impact of maternal HIV exposure, feeding status, and microbiome on infant cellular immunity.

Authors:  Sonwabile Dzanibe; Heather B Jaspan; Michael Z Zulu; Agano Kiravu; Clive M Gray
Journal:  J Leukoc Biol       Date:  2018-12-21       Impact factor: 4.962

4.  Low CD4+ T-cell levels and B-cell apoptosis in vertically HIV-exposed noninfected children and adolescents.

Authors:  Maristela Miyamoto; Silvana D Pessoa; Erika Ono; Daisy M Machado; Reinaldo Salomão; Regina C de M Succi; Savita Pahwa; Maria Isabel de Moraes-Pinto
Journal:  J Trop Pediatr       Date:  2010-04-13       Impact factor: 1.165

Review 5.  Impact of HIV-1 infection on the feto-maternal crosstalk and consequences for pregnancy outcome and infant health.

Authors:  Marcus Altfeld; Madeleine J Bunders
Journal:  Semin Immunopathol       Date:  2016-07-08       Impact factor: 9.623

Review 6.  The importance of the microbiome in pediatrics and pediatric infectious diseases.

Authors:  Thaidra Gaufin; Nicole H Tobin; Grace M Aldrovandi
Journal:  Curr Opin Pediatr       Date:  2018-02       Impact factor: 2.856

7.  Fc Characteristics Mediate Selective Placental Transfer of IgG in HIV-Infected Women.

Authors:  David R Martinez; Youyi Fong; Shuk Hang Li; Fang Yang; Madeleine F Jennewein; Joshua A Weiner; Erin A Harrell; Jesse F Mangold; Ria Goswami; George R Seage; Galit Alter; Margaret E Ackerman; Xinxia Peng; Genevieve G Fouda; Sallie R Permar
Journal:  Cell       Date:  2019-06-13       Impact factor: 41.582

Review 8.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

9.  Infectious Morbidity, Mortality and Nutrition in HIV-exposed, Uninfected, Formula-fed Infants: Results From the HPTN 040/PACTG 1043 Trial.

Authors:  Nava Yeganeh; D Heather Watts; Jiahong Xu; Tara Kerin; Esau C Joao; Jose Henrique Pilotto; Gerhard Theron; Glenda Gray; Breno Santos; Rosana Fonseca; Regis Kreitchmann; Jorge Pinto; Marisa M Mussi-Pinhata; Valdilea Veloso; Margaret Camarca; Lynne Mofenson; Jack Moye; Karin Nielsen-Saines
Journal:  Pediatr Infect Dis J       Date:  2018-12       Impact factor: 2.129

Review 10.  Immunology of pediatric HIV infection.

Authors:  Nicole H Tobin; Grace M Aldrovandi
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.